A new frontier in anaphylaxis management?
Ann Allergy Asthma Immunol
.
2023 Apr;130(4):411-412.
doi: 10.1016/j.anai.2023.01.021.
Author
Jay A Lieberman
1
Affiliation
1
Department of Pediatrics, The University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee. Electronic address: jlieber1@uthsc.edu.
PMID:
37005050
DOI:
10.1016/j.anai.2023.01.021
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anaphylaxis* / drug therapy
Epinephrine / therapeutic use
Humans
Substances
Epinephrine